ReederMJ, WarshawE, AravamuthanS, et al.Trends in the prevalence of methylchloroisothiazolinone/methylisothiazolinone contact allergy in North America and Europe. JAMA Dermatol. 2023; 159(3):267–274.
2.
UterW, WilkinsonSM, AertsO, et al.Patch test results with the European baseline series, 2019/20-Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC. Contact Dermatitis. 2022; 87(4):343–355.
3.
DeKovenJG, WarshawEM, ReederMJ, et al.North American Contact Dermatitis Group Patch Test Results: 2019–2020. Dermatitis. 2023; 34(2):90–104.
4.
SukakulT, KanchanapenkulD, BunyavareeM, et al.Methylchloroisothiazolinone and/or methylisothiazolinone in cosmetic products—a market survey. Contact Dermatitis. 2019; 80(2):110–113.
5.
FluryU, PalmerA, NixonR. The methylisothiazolinone contact allergy epidemic in Australia. Contact Dermatitis. 2018; 79(3):189–191.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
